bpc 157 peptide clinical studies BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded BPC-157 + TB-500 – Peptide
Description
Fourman, L.T., Czerwonka, N., Feldpausch, M.N., Weiss, J.J., Mamputu, J., Falutz, J.M., Morin, J., Marsolais, C., Stanley, T.L., & Grinspoon, S.K
It was originally developed as an anti-obesity drug , hence the name: Advanced Obesity Drug-9604
the direct clinical evidence here is for elamipretide (SS-31), not every peptide
Current Pharmaceutical Design , 2020 Injecting Far from the Injury Site (When Localized Healing Is Needed) If you're recovering from a joint, tendon, or ligament injury , injecting into the abdomen wont target the injured tissue as efficiently
What Improvement Can Look Like, and How Long It May Take When B12 is truly low, supplementation can support meaningful improvement
medial meniscus injury
